Your browser doesn't support javascript.
loading
Olaparib enhances sensitization of BRCA-proficient breast cancer cells to x-rays and protons.
Park, Sohee; Choi, Changhoon; Kim, Haeyoung; Shin, Yong Jae; Oh, Yunjeong; Park, Won; Cho, Won Kyung; Kim, Nalee.
Afiliação
  • Park S; Department of Radiation Oncology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Choi C; Department of Radiation Oncology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. chchoi93@gmail.com.
  • Kim H; Department of Radiation Oncology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. haeyoung0131.kim@samsung.com.
  • Shin YJ; Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. haeyoung0131.kim@samsung.com.
  • Oh Y; Innovative Institute for Precision Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Park W; Innovative Institute for Precision Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Cho WK; Department of Radiation Oncology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Kim N; Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Breast Cancer Res Treat ; 203(3): 449-461, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37902934

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Radiossensibilizantes / Neoplasias da Mama Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Radiossensibilizantes / Neoplasias da Mama Idioma: En Ano de publicação: 2024 Tipo de documento: Article